des-enkephalin-gamma-endorphin has been researched along with naloxone in 4 studies
| Studies (des-enkephalin-gamma-endorphin) | Trials (des-enkephalin-gamma-endorphin) | Recent Studies (post-2010) (des-enkephalin-gamma-endorphin) | Studies (naloxone) | Trials (naloxone) | Recent Studies (post-2010) (naloxone) |
|---|---|---|---|---|---|
| 41 | 6 | 0 | 20,134 | 1,257 | 3,321 |
| Protein | Taxonomy | des-enkephalin-gamma-endorphin (IC50) | naloxone (IC50) |
|---|---|---|---|
| Cytochrome P450 2D6 | Homo sapiens (human) | 2 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.043 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0219 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0019 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0019 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.0397 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.1896 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.05 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.0795 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.0154 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0089 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.0055 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andringa-Bakker, EA; de Rotte, AA; de Wied, D; van de Buuse, M; van Wimersma Greidanus, TB | 1 |
| Kay, N; Morley, JE; van Ree, JM | 1 |
| Di Giannuario, A; Loizzo, A; Luzi, M; Pieretti, S | 1 |
| Capasso, A | 1 |
4 other study(ies) available for des-enkephalin-gamma-endorphin and naloxone
| Article | Year |
|---|---|
The effect of gamma-type endorphins on alpha-MSH release in the rat.
Topics: Animals; Antipsychotic Agents; Apomorphine; beta-Endorphin; Dose-Response Relationship, Drug; Endorphins; gamma-Endorphin; Haloperidol; Injections, Intraventricular; Male; Melanocyte-Stimulating Hormones; Naloxone; Pituitary Gland, Anterior; Rats; Rats, Inbred Strains | 1985 |
Enhancement of human lymphocyte natural killing function by non-opioid fragments of beta-endorphin.
Topics: beta-Endorphin; Endorphins; gamma-Endorphin; Humans; Killer Cells, Natural; Naloxone; Peptide Fragments | 1987 |
Subchronic treatment with fragments of beta-endorphin prevents electroencephalographic seizures and behavioral alterations induced by centrally administered beta-endorphin in the rabbit.
Topics: Animals; Behavior, Animal; beta-Endorphin; Electroencephalography; Endorphins; Haloperidol; Injections, Intraventricular; Male; Naloxone; Peptide Fragments; Rabbits; Seizures | 1994 |
Beta-endorphin fragments DTgammaE and DEgammaE reduced morphine inhibition of electrically-induced contractions and opiate withdrawal.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Acetylcholine; Animals; beta-Endorphin; Electric Stimulation; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Guinea Pigs; Ileum; In Vitro Techniques; Jejunum; Male; Morphine; Muscle Contraction; Muscle, Smooth; Naloxone; Oligopeptides; Peptide Fragments; Rabbits; Substance Withdrawal Syndrome | 2009 |